The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
With the submission deadline approaching, we sat down with our research team to provide top tips on how to make your firm stand out
The 2025 list of Rising Stars and Corporate Stars, produced by Managing IP’s accreditation title IP STARS, is now available
The location will be easily accessible for delegates visiting London for the INTA Annual Meeting
Sponsored
-
Sponsored by Spoor & FisherDuncan Maguire and Paul Ramara of Spoor & Fisher explain how Tanzania’s recently introduced trademark recordation system now accepts ARIPO and foreign registrations, while national filings remain the strongest enforcement tool -
Sponsored by Adams & AdamsMohamed Jameel Hamid and Alicia van der Walt of Adams & Adams unpack the African Continental Free Trade Area agreement, explain its impact on intellectual property, and outline practical strategies for brand owners across Africa
-
Sponsored by Adams & AdamsLauren Ross and Melissa Morris of Adams & Adams discuss the strategic opportunities and challenges in protecting non-traditional trademarks across the continent’s diverse legal and regulatory landscape
The firm’s co-CEO discusses patent litigation, collaboration with overseas colleagues and the next generation of leaders
Aditi Verma Thakur, managing partner at Aishani Partners, discusses 5 am wake-ups, working with high-performing professionals and staying calm under pressure
Loke Khoon Tan and Stephanie Yip at Dentons explain what brand owners need to know ahead of January 1 2027, when updates to China’s Trade Mark Law come into force
New US bills signal that firms should work with clients to ensure they are complying with potential regulatory requirements
Sponsored
-
Sponsored by HANOL ClassHankyul IP & LawPrecision medicine, also known as personalised medicine, is an emerging field in healthcare and seems to have a promising future as it accounts for 42% of new molecular entities which the Food and Drug Administration (FDA) approved in 2018. Since precision medicine aims to provide bespoke medical treatments based on individual patient's characteristics, it essentially incorporates diagnosis and treatment methods. Under Korean patent law and practice, treatment and diagnosis methods are not considered patent eligible subject matter. As such, it is necessary to circumvent restrictive eligibility requirements to obtain protection for precision medicines in Korea. In the past, although precision medicines can be pursued as a pharmaceutical/diagnostic composition claim, it was not easy to claim methodological aspects of precision medicines (e.g. dosage regimen) which were not considered as technical features constituting composition itself (Supreme Court decisions 2007Hu2926 and 2007Hu2933, rendered on May 28 2009).
-
Sponsored by Remfry & SagarPankaj Soni of Remfry & Sagar analyses trends in AI, data concerns arising from AI, global subject matter eligibility standards for AI and whether AI can be classed as an inventor
-
Sponsored by HANOL ClassHankyul IP & LawIn Korea, patent term extension (PTE) of a maximum of five years may be granted once for a patent covering a drug or agrochemical that has to obtain marketing approval after patent registration. According to Article 95 of the Korean Patent Act, however, the scope of protection during the extended period is limited only to the working of the patented invention in relation to products whose marketing approval was the basis for PTE.
Patrade has turned to experienced IP practitioner and business development leader Anders Isaksson to strengthen its commercial strategy and expand its reach to clients across Scandinavia
K&L Gates and Baker Botts have recruited leading patent practitioners from Wende IP and EIP, respectively, as they seek to strengthen European patent litigation capabilities
By accepting a relatively small sample of infringing content to grant worldwide relief, a UK court has adopted a pragmatic approach that could reduce the time and expense involved in huge enforcement actions
As specialist boutiques challenge traditional firm models, major disputes involving Disney, Ericsson, Siemens and Dolby highlight the firms winning work before the UPC
Sponsored
-
Sponsored by Gün + PartnersSelin Sinem Erciyas of Gün + Partners examines whether the EU Pharma Package’s expanded Bolar exemption aligns with the TRIPS Agreement, drawing lessons from Türkiye’s long-standing pharmaceutical patent jurisprudence
-
Sponsored by INLEXIgor Charles and Théo Coquis of INLEX analyse a Paris Judicial Court ruling confirming that trademark exhaustion applies to bundled genuine products where the original packaging remains unaltered
-
Sponsored by MaiwaldKerstin Wolff of Maiwald explains how patents, plant variety rights, and new genomic techniques intersect in Europe, and what breeders and biotech innovators should consider when protecting plant intellectual property
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
New awards, including US ‘Firm of the Year’ and Latin America ‘Firm to Watch’, are among more than 90 prizes that will recognise firms and practitioners
The shortlist for our annual Americas Awards will be published next month, with potential winners in more than 90 categories set to be revealed
A new foundation in Chile is giving women in the IP community the mentorship, and visibility they’ve long lacked
Sponsored
-
Sponsored by Licks AttorneysEduardo Hallak, Juliana Neves, and Sarah Lucas of Licks Attorneys examine Brazil's growing debate over patent term adjustment and the legislative proposals seeking to address examination delays
-
Sponsored by Becerril, Coca & BecerrilStephania Cardiel of Becerril, Coca & Becerril examines how recent reforms signal a regional move towards faster, more internationally aligned innovation systems
-
Sponsored by Daniel LawRoberta Arantes of Daniel Law looks at how the Brazilian legal landscape has responded to shifts in the concept of branding and its related levels of protection
Ten firms have each received more than 11 nominations, while more than 20 in-house counsel are up for awards
We look ahead to next month’s EMEA Awards, discussing the recently published shortlists, our research methodology and what makes the Awards special
Managing IP will host a ceremony in London on April 10 to reveal the winners of the EMEA Awards 2025
Practitioners and law firms should keep their eyes peeled as the shortlist for our annual Awards is set to be released
Apple’s lawsuit against OpenAI, which features Tier 1-ranked disputes firms on both sides, reflects how trade secrets litigation is becoming a prominent competition feature
Amongst a sea of mergers, Lathrop GPM and HG Law have set out plans to combine, positioning themselves to compete with both IP boutiques and full-service firms
Nick Redfearn, head of enforcement at Rouse and a classic car enthusiast, explains the sudden viral appearance of classic car restomod parts from China and the impact of IP in this new trade
The move marks the latest step in Temu’s push to protect brands’ intellectual property by collaborating with industry groups and enforcement agencies. Managing IP learns about a rapidly scaling strategy and two success stories
Sponsored
-
Sponsored by Red PointsRed Points, in partnership with Managing IP hosted a webinar on April 7 at 9am PDT / 12pm EDT / 5pm BST to discuss best practices in uncovering and dismantling large-scale counterfeiters
-
Sponsored by OLIVARESMauricio Sámano of OLIVARES explores how the pandemic has changed IP processes for businesses in Mexico
-
Sponsored by OLIVARESSantiago Pedroza of OLIVARES looks at how the opposition procedure has undergone changes to protect right holders
